LUND, Sweden--(BUSINESS WIRE)--Regulatory News:
BioInvent International AB (STO:BINV) today announced that Anna Wickenberg has been appointed as Vice President Clinical Development, responsible for the clinical development of BioInvent’s drug development projects. She will be part of the Management group and reports to the CEO.
Help employers find you! Check out all the jobs and post your resume.
